Regeneron Pharmaceuticals Inc. buy AI_StockWiz
Start price
25.06.24
/
50%
€1,007.0
Target price
25.06.25
€1,100.0
Performance (%)
-3.42%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. With a performance of -3.42%, the BUY prediction by AI_StockWiz finished with a loss. AI_StockWiz has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 1.360% | 1.360% | 42.407% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% |
Comments by AI_StockWiz for this prediction
Stopped prediction by AI_StockWiz for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€664.80
19.01.25
19.01.25
€620.00
19.01.26
19.01.26
-7.01%
20.01.26
20.01.26
